Potential Implications of GRP58 Expression and Susceptibility of Cervical Cancer to Cisplatin and Thymoquinone-Based Therapy
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s62928
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2014
Authors
Publisher
Informa UK Limited